Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease
Tatsuya Kanto, Sachiyo Yoshio
Citation Information :
Kanto T, Yoshio S. Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease. Euroasian J Hepatogastroenterol 2017; 7 (1):60-64.
Kanto T, Yoshio S. Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2017;7(1):60-64.
JSH guidelines for the management of hepatitis C virus infection: a 2014 update for genotype 1. Hepatol Res 2014 Jan;44(Suppl 1):59-70. [cited 2014 Jan 7]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/hepr.12272/abstract.
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol 2015 Mar;50(3):350-360.
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep 2016 Jul;6:28814.